Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis B Silverman

Showing results (141-150 of 188) with videos related to

Pageof 19
Sort By:
Haematologica|February 3, 2022
Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001)Sarah K Tasian, Lewis B Silverman, James A Whitlock, et al.
British Journal of Haematology|December 25, 2025
Philadelphia chromosome-positive acute lymphoblastic leukaemia in children and adolescents: A changing treatment landscape and a methodological challengeAdriana Balduzzi, Maria Grazia Valsecchi, Thai Hoa Tran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2022
Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/<i>KMT2A</i> Rearrangements in a Modern Therapy Era: A Retrospective International StudyAndishe Attarbaschi, Anja Möricke, Christine J Harrison, et al.
British Journal of Haematology|August 14, 2024
Genome-wide study identifies novel genes associated with bone toxicities in children with acute lymphoblastic leukaemiaQianqian Zhu, Ram Nambiar, Emily Schultz, et al.
Blood|July 2, 2010
Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 StudyGeorg Mann, Andishe Attarbaschi, Martin Schrappe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2013
Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institute ALL Consortium Protocol 00-01Lynda M Vrooman, Kristen E Stevenson, Jeffrey G Supko, et al.
Pediatrics|November 21, 2012
Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac OutcomesSteven E Lipshultz, Tracie L Miller, Stuart R Lipsitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Childhood Acute Lymphoblastic Leukemia: Progress Through CollaborationChing-Hon Pui, Jun J Yang, Stephen P Hunger, et al.
The Lancet. Oncology|September 21, 2010
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trialSteven E Lipshultz, Rebecca E Scully, Stuart R Lipsitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2010
Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Suzanne E Dahlberg, Donna S Neuberg, et al.
Pageof 19

Showing results (141-150 of 188) with videos related to

Sort By:
Pageof 19
Haematologica|February 3, 2022
Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001)Sarah K Tasian, Lewis B Silverman, James A Whitlock, et al.
British Journal of Haematology|December 25, 2025
Philadelphia chromosome-positive acute lymphoblastic leukaemia in children and adolescents: A changing treatment landscape and a methodological challengeAdriana Balduzzi, Maria Grazia Valsecchi, Thai Hoa Tran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2022
Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/<i>KMT2A</i> Rearrangements in a Modern Therapy Era: A Retrospective International StudyAndishe Attarbaschi, Anja Möricke, Christine J Harrison, et al.
British Journal of Haematology|August 14, 2024
Genome-wide study identifies novel genes associated with bone toxicities in children with acute lymphoblastic leukaemiaQianqian Zhu, Ram Nambiar, Emily Schultz, et al.
Blood|July 2, 2010
Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 StudyGeorg Mann, Andishe Attarbaschi, Martin Schrappe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2013
Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institute ALL Consortium Protocol 00-01Lynda M Vrooman, Kristen E Stevenson, Jeffrey G Supko, et al.
Pediatrics|November 21, 2012
Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac OutcomesSteven E Lipshultz, Tracie L Miller, Stuart R Lipsitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Childhood Acute Lymphoblastic Leukemia: Progress Through CollaborationChing-Hon Pui, Jun J Yang, Stephen P Hunger, et al.
The Lancet. Oncology|September 21, 2010
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trialSteven E Lipshultz, Rebecca E Scully, Stuart R Lipsitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2010
Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Suzanne E Dahlberg, Donna S Neuberg, et al.
Pageof 19